News and
press releases

News

Introducing the Bioscientifica Trust

The Bioscientifica Trust has been established to offer funding to assist early-career scientists and clinicians in biomedicine and the life sciences.

Bioscientifica launches author resource centre

Bioscientifica authors are now able to learn more about the publication process, from preparing their papers to post-publication promotion, using the author resource centre.

Bioscientifica partners with Enago

Bioscientifica has partnered with Enago, a world-leading academic editing service provider, to offer discounted English editing services to authors.

Bioscientifica partners with Sheridan PubFactory

Bioscientifica are delighted to announce a partnership with Sheridan PubFactory that will see all titles published by Bioscientifica hosted on the PubFactory platform from Summer 2018. This partnership will enable heightened service to society partners. 

Bioscientifica announce 2016 impact factors

Bioscientifica have again announced substantial growth in the impact factors of their biomedical journals in the latest Journal Citation Reports (JCR).

View archive

Press releases

Potential new target for reducing osteoporosis risk in men

Researchers have identified a new regulator of vitamin D metabolism that could be targeted to reduce the risk of osteoporosis in men undergoing prostate cancer therapy, according to a study published in the Journal of Molecular Endocrinology.

Successful male infertility treatment does not lower fertility of sons

The most common procedure for treating infertility in men does not adversely affect the fertility of their sons, according to a review published in the journal Reproduction. Intracytoplasmic sperm injection (ICSI) is the most effective and successful treatment for male infertility and this review reports that there is no clear evidence for any adverse effects on the fertility of boys conceived using the procedure.

Warm temperatures can lead to misdiagnosis of diabetes in pregnancy

Environmental temperatures of over 25 degrees are associated with a significant increase in the risk of being misdiagnosed with gestational diabetes during pregnancy, data published in the European Journal of Endocrinology suggests. Misdiagnosis of the condition could lead to unnecessary insulin treatment and avoidable distress for prospective mothers.

Guidelines for management of recurrent pituitary tumours recommend new drug as first line treatment

New guidelines for managing recurrent pituitary tumours identify the drug temozolomide, as first line chemotherapy treatment. The guidelines, published in the European Journal of Endocrinology and produced by the European Society of Endocrinology (ESE), include a series of recommendations aimed at improving survival rates and quality of life for patients, through early identification of tumours and more effective treatment strategies.

Taking paracetamol during pregnancy may reduce fertility of daughters

Taking paracetamol during pregnancy may impair the future fertility of female offspring, according to a review published in Endocrine Connections. The article reviews three separate rodent studies that all report altered development in the reproductive systems of female offspring from mothers given paracetamol during pregnancy, which may impair their fertility in adulthood.

View archive

Contact

Bioscientifica press office:
media@bioscientifica.com